GOLDEN fusion: a graph-oriented learning with domain-embedding network fusion for generating super gene sets in functional genomics
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 95 of the 95 references it cites were found in a registry or an index; 6 of the 11 sources its claims cite were checked for support.
Abstract
The integrative analysis of gene sets, networks, and pathways is pivotal for deciphering omics data in translational biomedical research. To significantly increase gene coverage and enhance the utility of gene sets from diverse sources, we introduced pathways, annotated gene lists, and gene signatures (PAGs) enriched with metadata to represent biological functions. Furthermore, we established PAG-PAG networks by leveraging gene member similarity and gene regulations. However, in practice, high similarity in descriptions and gene membership often produces redundant, lengthy PAG lists, leading to gene set enrichment results that are difficult to interpret. We present Graph-Oriented Learning with Domain-Embedding Network (GOLDEN) fusion, an integrative framework that jointly leverages (i) connection-based embeddings derived from PAG-PAG relationships and (ii) semantic-based embeddings learned from PAG descriptions with a large language model (LLM). The two representations are combined via early fusion with a tunable weighting to produce a unified embedding on which clustering identifies concise, higher-level super-PAG. To assess when clustering is appropriate, we introduce a Connection Disparity Index, trained on synthetic stochastic block models, as a proxy for network "clusterability." We further optimize the number of clusters with consensus clustering. On Gene Ontology Annotation biological process benchmarks, GOLDEN fusion recovers is-a structure more accurately than either connection-only or semantic-only baselines, demonstrating consistent gains in Adjusted Rand Index and Normalized Mutual Information. Finally, we generate summaries for each super-PAG by synthesizing its member PAG descriptions using a comparative analysis of LLMs. GOLDEN fusion provides an integrated framework for interpreting omics results.
Overview
CoChat Summary
TL;DR
GOLDEN fusion combines graph embeddings from PAG–PAG networks with LLM-derived semantic embeddings to generate higher-level super-PAGs, using a Connection Disparity Index (CDI) to assess clusterability. On Gene Ontology Annotation benchmarks it outperforms graph-only and semantic-only baselines and provides LLM-generated summaries for super-PAGs.
Key findings
- GOLDEN fusion (weighted graph + semantic fusion) achieved higher ARI than either single-source baseline on GOA SPAGs 5–10 and SPAGs 10–100; the best configurations favored the semantic channel at α ≈ 0.8, and 256-d Node2Vec + 512-d OpenAI embeddings were recommended for the accuracy–efficiency trade-off.
- Graph-only clustering was best with Agglomerative Clustering (mean ARI 0.51 for SPAGs 5–10; 0.29 for SPAGs 10–100), while semantic-only clustering was also best with Agglomerative Clustering (mean ARI 0.66 and 0.55, respectively); HDBSCAN was lowest (0.01–0.12). GOLDEN fusion outperformed REVIGO, GOSemSim, ReCiPa, and clusterProfiler across both benchmarks.
- The CDI predictive model classified synthetic networks into unclusterable and clusterable categories with accuracy 0.88 and F1 score 0.9; random forest achieved F1 = 0.90. In SPAG 5–10 pairs, weak functional relevance accounted for 40.0% of CDI-high pairs versus 9.1% of CDI-low pairs, while moderate relevance was 54.5% versus 30.0%.
- GPT-4.1 gave the highest cosine similarity for PAG summarization: 0.71 ± 0.10 on SPAGs 5–10 and 0.72 ± 0.13 on SPAGs 10–100. In a CML TKI-resistant versus sensitive case study, GOLDEN fusion stabilized at k = 2 with CDI = 0.997.
Methods
- Inputs are PAG IDs or gene lists processed through PAGER 3.0; the method builds an m-type PAG–PAG graph weighted by hypergeometric gene-overlap significance, learns Node2Vec graph embeddings, generates semantic embeddings from PAG descriptions using OpenAI text-embedding-3-small, aligns them by PCA, L2-normalizes, and fuses them with a tunable weight α. Clustering is performed on the fused representation, with consensus clustering to choose k, followed by LLM summarization of each super-PAG.
- Benchmarks include the GOA biological process m-type PAG–PAG network with GOA is-a relations as ground truth: SPAGs 5–10 (300 two-member groups) and SPAGs 10–100 (127 two-member groups). KEGG and Reactome pathway datasets were also used with repeated random sampling (300 trials, 2 categories, up to 20 pathways per category). Synthetic SBMs and DC-SBMs were used to train CDI models.
- Performance was evaluated mainly with ARI and NMI against ground-truth labels; CDI was trained on clustering coefficient distribution features using classifiers including logistic regression, SVM, KNN, random forest, and XGBoost for CDI-β.
Limitations
- Stated: LLM-generated summaries lack human curation and are intended to support interpretation/navigation, not replace curated ontology definitions or expert annotation; super-PAGs are currently flattened one-level structures; higher edge thresholds can improve pattern representation but reduce network coverage; integrating multi-modality relationships increases modeling complexity; and beyond CML, additional experimental or literature-based validation of identified super-PAGs is needed.
- Evident from the provided text: several method and result sections are empty or fragmented, so details of CDI-based separation and PAG summarization are incomplete; benchmark ground truth relies on GOA is-a and pathway hierarchies rather than independent experimental validation.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
3 Valid · 0 Not valid · 1 Not checked · 74 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“One cluster summarized the concepts related to the development of resistance to chemotherapy drugs, rendering the treatment ineffective in inhibiting cancer cell proliferation or inducing cell death. This discovery has been repeatedly validated through experimental results from BCR-ABL kinase-independent pathways that promote CML cell survival and proliferation, bypassing TKI inhibition [84, 85].”
§ GOLDEN fusion: a graph-oriented learning with domain-embedding network fusion for generating super gene sets in functional genomics > Results > Case study of chronic myeloid leukemia tyrosine kinase inhibitor resistant versus sensitive
What the sources say
- Supportedcites [84] Alves, 2021, Resistance to tyrosine kinase inhibitors in chronic myeloid leukemia-from molecular mechanisms to clinical relevance, Cancers (Basel) source
Section 2.4, “Alternative Signaling Pathways” (page unavailable), states that CML cells can activate alternative pathways and continue to proliferate and survive despite effective BCR-ABL1 inhibition. This supports the BCR-ABL1-independent TKI-resistance mechanism attributed to the source; the description of the cluster is the citing authors’ own finding. (LLM, conf=0.90)
- Partly supportedcites [85] Jabbour, 2013, Resistance to tyrosine kinase inhibition therapy for chronic myelogenous leukemia: a clinical perspective and emerging treatment options, Clin Lymphoma Myeloma Leuk sourceExperimental — accuracy not yet measured
The sections on alternative signaling pathways and stem-cell persistence report BCR-ABL-independent mechanisms by which CML cells survive imatinib treatment, with cytokine support permitting growth. The paper describes the Src pathway as one that “seems” critical and says the clinical significance of some resistance mechanisms remains under investigation; it does not establish the citing sentence’s stronger claim of repeated experimental validation. (LLM, conf=0.82)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“we found that Spectral Clustering consistently outperformed the other two algorithms in accurately detecting the underlying cluster structures.”
§ GOLDEN fusion: a graph-oriented learning with domain-embedding network fusion for generating super gene sets in functional genomics > Results > Exploring clusterability: the performance of clusterability predictive model
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“On Gene Ontology Annotation biological process benchmarks, GOLDEN fusion recovers is-a structure more accurately than either connection-only or semantic-only baselines, demonstrating consistent gains in Adjusted Rand Index and Normalized Mutual Information.”
- Also stated in: § Introduction · boosted
“We tested GOLDEN fusion on the Gene Ontology (GO) network and demonstrated that GOLDEN fusion outperforms baseline models that utilize any individual information in generating super-PAG.”
§ GOLDEN fusion: a graph-oriented learning with domain-embedding network fusion for generating super gene sets in functional genomics > Abstract
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Also stated in: § Introduction · boosted
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The clusterability predictive model was designed to classify synthetic networks into unclusterable and clusterable categories with an accuracy of 0.88 and an F1 score of 0.9.”
§ GOLDEN fusion: a graph-oriented learning with domain-embedding network fusion for generating super gene sets in functional genomics > Results > Exploring clusterability: the performance of clusterability predictive model
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As shown in the ARI measurement heatmap in Fig. 2, a clear boundary emerges that separates networks that can be reliably clustered from those that cannot.”
§ GOLDEN fusion: a graph-oriented learning with domain-embedding network fusion for generating super gene sets in functional genomics > Results > Exploring clusterability: the performance of clusterability predictive model
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
40 more claims
Create a free account to see all 78 claims and every source verdict.
- It may state two separate claims as one. 26
- Probably not a substantial claim. 13
- The quote only partly states this claim. 2
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ GOLDEN fusion: a graph-oriented learning with domain-embedding network fusion for generating super gene sets in functional genomics > Methods > Overview design of GOLDEN fusion workflow
“We performed early fusion of this information by concatenating their embeddings and applying a hyperparameter α to adjust the weight of each data source, resulting in a new embedding matrix Df.”
§ GOLDEN fusion: a graph-oriented learning with domain-embedding network fusion for generating super gene sets in functional genomics > Methods > Fusion and consensus clustering
“We form an embedding fusion for each PAG by taking a weighted linear blend of its Node2Vec vector and its description vector.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ GOLDEN fusion: a graph-oriented learning with domain-embedding network fusion for generating super gene sets in functional genomics > Methods > Fusion and consensus clustering
“${D}_{f,i}=\left(1-\alpha \right){D}_{g,i}+\alpha{D}_{g,i}$”
§ GOLDEN fusion: a graph-oriented learning with domain-embedding network fusion for generating super gene sets in functional genomics > Methods > Fusion and consensus clustering
“α = 0 corresponds to using only the graph embeddings, α = 1 uses only description embeddings, and intermediate values blend the two.”
Citations
Cites
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Yu, G., Wang, L.-G., Han, Y., & He, Q.-Y. (2012) · OMICS: A Journal of Integrative Biology · doi:10.1089/omi.2011.0118 · Cited by 36,259 · cited 1×
“…redundancy control, e.g. ReCiPa [ 63] (max overlapping is 0.7, and low overlapping is 0.5), and overlap-based clustering, e.g. clusterProfiler [ 74] (default cutoff is 0.7), we applied all methods to the same GOA-derived benchmark datasets (SPAGs 5–10 and SPAGs 10–100) and evaluated using ARI…”
InfluentialEnrichr: a comprehensive gene set enrichment analysis web server 2016 update
Kuleshov, M. V., Jones, M. R., Rouillard, A. D., Fernandez, N. F., Duan, Q., Wang, Z., Koplev, S., Jenkins, S. L., Jagodnik, K. M., Lachmann, A., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw377 · Cited by 10,799 · cited 1×
“These include Gorilla [ 31], DAVID [ 32], WebGestalt [ 33], EnrichR [ 34], PANTHER Gene List Analysis [ 35], TermMapper [ 36], and g:profiler [ 37], which are frequently used to provide valuable interpretations into high-throughput omics.”
REVIGO summarizes and visualizes long lists of gene ontology terms
Supek, F., Bošnjak, M., Škunca, N., & Šmuc, T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021800 · Cited by 6,264 · cited 1×
“…GOLDEN fusion against the established similarity-based redundancy reduction and clustering methods, including semantic similarity, e.g. REVIGO [ 71] (default similarity cutoff is 0.7) and the Lin measure via GOSemSim [ 72, 73] (default similarity cutoff is 0.7), Jaccard-based redundancy…”
InfluentialSherman, B. T., Hao, M., Qiu, J., Jiao, X., Baseler, M. W., Lane, H. C., Imamichi, T., & Chang, W. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac194 · Cited by 6,142 · cited 1×
“These include Gorilla [ 31], DAVID [ 32], WebGestalt [ 33], EnrichR [ 34], PANTHER Gene List Analysis [ 35], TermMapper [ 36], and g:profiler [ 37], which are frequently used to provide valuable interpretations into high-throughput omics.”
KEGG for taxonomy-based analysis of pathways and genomes
Kanehisa, M., Furumichi, M., Sato, Y., Kawashima, M., & Ishiguro-Watanabe, M. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkac963 · Cited by 5,833 · cited 1×
“…has significantly enhanced the analytical power, enabling comprehensive analysis from various sources, including pathways (Reactome [ 44], KEGG [ 45], BioCarta, WikiPathways [ 46], DMaps [ 47], SPIKE, NCI Nature Curated pathway [ 48], and GeoMx Cancer Transcriptome Atlas [ 49]), ontology…”
Raudvere, U., Kolberg, L., Kuzmin, I., Arak, T., Adler, P., Peterson, H., & Vilo, J. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz369 · Cited by 5,045 · cited 1×
“These include Gorilla [ 31], DAVID [ 32], WebGestalt [ 33], EnrichR [ 34], PANTHER Gene List Analysis [ 35], TermMapper [ 36], and g:profiler [ 37], which are frequently used to provide valuable interpretations into high-throughput omics.”
The Gene Ontology Resource: 20 years and still GOing strong
The Gene Ontology Consortium (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1055 · Cited by 4,747 · cited 1×
“…DMaps [ 47], SPIKE, NCI Nature Curated pathway [ 48], and GeoMx Cancer Transcriptome Atlas [ 49]), ontology annotations (Gene Ontology Annotation [ 50] also known as GOA and Human Phenotype Ontology), tissue-specific expressions (GTEx [ 51], NGS Catalog [ 52], and TCGA [ 53], PathologyAtlas […”
Review The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge
Tomczak, K., Czerwińska, P., & Wiznerowicz, M. (2015) · Współczesna Onkologia · doi:10.5114/wo.2014.47136 · Cited by 3,492
A pathology atlas of the human cancer transcriptome
Uhlen, M., Zhang, C., Lee, S., Sjöstedt, E., Fagerberg, L., Bidkhori, G., Benfeitas, R., Arif, M., Liu, Z., Edfors, F., et al. (2017) · Science · doi:10.1126/science.aan2507 · Cited by 3,371 · cited 1×
“…[ 50] also known as GOA and Human Phenotype Ontology), tissue-specific expressions (GTEx [ 51], NGS Catalog [ 52], and TCGA [ 53], PathologyAtlas [ 54], and FANTOM5 [ 55]), cell-specific expressions (CellAtlas [ 56]), disease phenotypes (GAD, GWAS Catalog [ 57], Phewas [ 58], and Online Mendelian…”
GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists
Eden, E., Navon, R., Steinfeld, I., Lipson, D., & Yakhini, Z. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-48 · Cited by 3,356
WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs
Liao, Y., Wang, J., Jaehnig, E. J., Shi, Z., & Zhang, B. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz401 · Cited by 3,144 · cited 1×
“These include Gorilla [ 31], DAVID [ 32], WebGestalt [ 33], EnrichR [ 34], PANTHER Gene List Analysis [ 35], TermMapper [ 36], and g:profiler [ 37], which are frequently used to provide valuable interpretations into high-throughput omics.”
The Reactome Pathway Knowledgebase
Fabregat, A., Jupe, S., Matthews, L., Sidiropoulos, K., Gillespie, M., Garapati, P., Haw, R., Jassal, B., Korninger, F., May, B., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1132 · Cited by 2,855
Regev, A., Teichmann, S. A., Lander, E. S., Amit, I., Benoist, C., Birney, E., Bodenmiller, B., Campbell, P., Carninci, P., Clatworthy, M., et al. (2017) · eLife · doi:10.7554/elife.27041 · Cited by 2,232 · cited 1×
“…expressions (GTEx [ 51], NGS Catalog [ 52], and TCGA [ 53], PathologyAtlas [ 54], and FANTOM5 [ 55]), cell-specific expressions (CellAtlas [ 56]), disease phenotypes (GAD, GWAS Catalog [ 57], Phewas [ 58], and Online Mendelian Inheritance in Man), drug–targets (PharmGKB [ 59] and DSigDB […”
Boyle, E. I., Weng, S., Gollub, J., Jin, H., Botstein, D., Cherry, J. M., & Sherlock, G. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth456 · Cited by 2,067 · cited 1×
“These include Gorilla [ 31], DAVID [ 32], WebGestalt [ 33], EnrichR [ 34], PANTHER Gene List Analysis [ 35], TermMapper [ 36], and g:profiler [ 37], which are frequently used to provide valuable interpretations into high-throughput omics.”
Stochastic blockmodels and community structure in networks
Karrer, B., & Newman, M. E. J. (2011) · Physical Review E · doi:10.1103/physreve.83.016107 · Cited by 2,025 · cited 2×
“Currently, the CDI is built on synthetic data from stochastic block models (SBMs) and degree-corrected stochastic block models (DC-SBMs) [ 68] to infer whether the network can be clustered into super-PAG based on the distribution of the clustering coefficient [ 69].”
The NHGRI-EBI GWAS Catalog: knowledgebase and deposition resource
Sollis, E., Mosaku, A., Abid, A., Buniello, A., Cerezo, M., Gil, L., Groza, T., Güneş, O., Hall, P., Hayhurst, J., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkac1010 · Cited by 1,641 · cited 1×
“…52], and TCGA [ 53], PathologyAtlas [ 54], and FANTOM5 [ 55]), cell-specific expressions (CellAtlas [ 56]), disease phenotypes (GAD, GWAS Catalog [ 57], Phewas [ 58], and Online Mendelian Inheritance in Man), drug–targets (PharmGKB [ 59] and DSigDB [ 60]), and miRNA–gene interactions (Microcosm…”
PID: the Pathway Interaction Database
Schaefer, C. F., Anthony, K., Krupa, S., Buchoff, J., Day, M., Hannay, T., & Buetow, K. H. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn653 · Cited by 1,603 · cited 1×
“…from various sources, including pathways (Reactome [ 44], KEGG [ 45], BioCarta, WikiPathways [ 46], DMaps [ 47], SPIKE, NCI Nature Curated pathway [ 48], and GeoMx Cancer Transcriptome Atlas [ 49]), ontology annotations (Gene Ontology Annotation [ 50] also known as GOA and Human Phenotype…”
The biochemical basis of microRNA targeting efficacy
(2019) · doi:10.1126/science.aav1741 · Cited by 1,570 · cited 1×
“…FANTOM5 [ 55]), cell-specific expressions (CellAtlas [ 56]), disease phenotypes (GAD, GWAS Catalog [ 57], Phewas [ 58], and Online Mendelian Inheritance in Man), drug–targets (PharmGKB [ 59] and DSigDB [ 60]), and miRNA–gene interactions (Microcosm Targets, TargetScan [ 61], and mirTARbase [ 62]).”
Mi, H., Muruganujan, A., Huang, X., Ebert, D., Mills, C., Guo, X., & Thomas, P. D. (2019) · Nature Protocols · doi:10.1038/s41596-019-0128-8 · Cited by 1,493 · cited 1×
“These include Gorilla [ 31], DAVID [ 32], WebGestalt [ 33], EnrichR [ 34], PANTHER Gene List Analysis [ 35], TermMapper [ 36], and g:profiler [ 37], which are frequently used to provide valuable interpretations into high-throughput omics.”
GOSemSim: an R package for measuring semantic similarity among GO terms and gene products
Yu, G., Li, F., Qin, Y., Bo, X., Wu, Y., & Wang, S. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq064 · Cited by 1,388 · cited 1×
“…and clustering methods, including semantic similarity, e.g. REVIGO [ 71] (default similarity cutoff is 0.7) and the Lin measure via GOSemSim [ 72, 73] (default similarity cutoff is 0.7), Jaccard-based redundancy control, e.g. ReCiPa [ 63] (max overlapping is 0.7, and low overlapping is 0.5),…”
InfluentialBioGPT: generative pre-trained transformer for biomedical text generation and mining
Luo, R., Sun, L., Xia, Y., Qin, T., Zhang, S., Poon, H., & Liu, T.-Y. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac409 · Cited by 1,150 · cited 1×
“5, BART-based variants, SciFive [ 75], Pegasus [ 76], BioGPT [ 77], BioBART [ 78], BioRAgent [ 79], and Flan-T5 [ 80].”
Clustering in weighted networks
Opsahl, T., & Panzarasa, P. (2009) · Social Networks · doi:10.1016/j.socnet.2009.02.002 · Cited by 1,037 · cited 1×
“Currently, the CDI is built on synthetic data from stochastic block models (SBMs) and degree-corrected stochastic block models (DC-SBMs) [ 68] to infer whether the network can be clustered into super-PAG based on the distribution of the clustering coefficient [ 69].”
Denny, J. C., Bastarache, L., Ritchie, M. D., Carroll, R. J., Zink, R., Mosley, J. D., Field, J. R., Pulley, J. M., Ramirez, A. H., Bowton, E., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2749 · Cited by 1,013 · cited 1×
“…[ 53], PathologyAtlas [ 54], and FANTOM5 [ 55]), cell-specific expressions (CellAtlas [ 56]), disease phenotypes (GAD, GWAS Catalog [ 57], Phewas [ 58], and Online Mendelian Inheritance in Man), drug–targets (PharmGKB [ 59] and DSigDB [ 60]), and miRNA–gene interactions (Microcosm Targets,…”
Huang, H.-Y., Lin, Y.-C.-D., Cui, S., Huang, Y., Tang, Y., Xu, J., Bao, J., Li, Y., Wen, J., Zuo, H., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkab1079 · Cited by 983 · cited 1×
“…FANTOM5 [ 55]), cell-specific expressions (CellAtlas [ 56]), disease phenotypes (GAD, GWAS Catalog [ 57], Phewas [ 58], and Online Mendelian Inheritance in Man), drug–targets (PharmGKB [ 59] and DSigDB [ 60]), and miRNA–gene interactions (Microcosm Targets, TargetScan [ 61], and mirTARbase [ 62]).”
Pegasus, a workflow management system for science automation
Deelman, E., Vahi, K., Juve, G., Rynge, M., Callaghan, S., Maechling, P. J., Mayani, R., Chen, W., Ferreira da Silva, R., Livny, M., et al. (2015) · Future Generation Computer Systems · doi:10.1016/j.future.2014.10.008 · Cited by 861 · cited 1×
“5, BART-based variants, SciFive [ 75], Pegasus [ 76], BioGPT [ 77], BioBART [ 78], BioRAgent [ 79], and Flan-T5 [ 80].”
DSigDB: drug signatures database for gene set analysis
Yoo, M., Shin, J., Kim, J., Ryall, K. A., Lee, K., Lee, S., Jeon, M., Kang, J., & Tan, A. C. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv313 · Cited by 750 · cited 1×
“…FANTOM5 [ 55]), cell-specific expressions (CellAtlas [ 56]), disease phenotypes (GAD, GWAS Catalog [ 57], Phewas [ 58], and Online Mendelian Inheritance in Man), drug–targets (PharmGKB [ 59] and DSigDB [ 60]), and miRNA–gene interactions (Microcosm Targets, TargetScan [ 61], and mirTARbase [ 62]).”
The Genotype-Tissue Expression (GTEx) Project
Carithers, L. J., & Moore, H. M. (2015) · Biopreservation and Biobanking · doi:10.1089/bio.2015.29031.hmm · Cited by 549
WikiPathways 2024: next generation pathway database
Agrawal, A., Balcı, H., Hanspers, K., Coort, S. L., Martens, M., Slenter, D. N., Ehrhart, F., Digles, D., Waagmeester, A., Wassink, I., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkad960 · Cited by 460 · cited 1×
“…the analytical power, enabling comprehensive analysis from various sources, including pathways (Reactome [ 44], KEGG [ 45], BioCarta, WikiPathways [ 46], DMaps [ 47], SPIKE, NCI Nature Curated pathway [ 48], and GeoMx Cancer Transcriptome Atlas [ 49]), ontology annotations (Gene Ontology…”
Gene ontology semantic similarity analysis using GOSemSim
Yu, G. (2020) · Methods in Molecular Biology · doi:10.1007/978-1-0716-0301-7_11 · Cited by 392 · cited 1×
“…and clustering methods, including semantic similarity, e.g. REVIGO [ 71] (default similarity cutoff is 0.7) and the Lin measure via GOSemSim [ 72, 73] (default similarity cutoff is 0.7), Jaccard-based redundancy control, e.g. ReCiPa [ 63] (max overlapping is 0.7, and low overlapping is 0.5), and…”
InfluentialPharmGKB: A worldwide resource for pharmacogenomic information
Barbarino, J. M., Whirl‐Carrillo, M., Altman, R. B., & Klein, T. E. (2018) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1417 · Cited by 358 · cited 1×
“…FANTOM5 [ 55]), cell-specific expressions (CellAtlas [ 56]), disease phenotypes (GAD, GWAS Catalog [ 57], Phewas [ 58], and Online Mendelian Inheritance in Man), drug–targets (PharmGKB [ 59] and DSigDB [ 60]), and miRNA–gene interactions (Microcosm Targets, TargetScan [ 61], and mirTARbase [ 62]).”
Multilevel omics for the discovery of biomarkers and therapeutic targets for stroke
Montaner, J., Ramiro, L., Simats, A., Tiedt, S., Makris, K., Jickling, G. C., Debette, S., Sanchez, J.-C., & Bustamante, A. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0350-6 · Cited by 330 · cited 1×
“These include molecular risk stratification [ 6– 8], preclinical drug screening [ 9– 11], prognosis prediction [ 12– 14], new biomarker discovery [ 15– 17], and precision medicine [ 18– 20].”
FANTOM5 CAGE profiles of human and mouse samples
Noguchi, S., Arakawa, T., Fukuda, S., Furuno, M., Hasegawa, A., Hori, F., Ishikawa-Kato, S., Kaida, K., Kaiho, A., Kanamori-Katayama, M., et al. (2017) · Scientific Data · doi:10.1038/sdata.2017.112 · Cited by 310 · cited 1×
“…GOA and Human Phenotype Ontology), tissue-specific expressions (GTEx [ 51], NGS Catalog [ 52], and TCGA [ 53], PathologyAtlas [ 54], and FANTOM5 [ 55]), cell-specific expressions (CellAtlas [ 56]), disease phenotypes (GAD, GWAS Catalog [ 57], Phewas [ 58], and Online Mendelian Inheritance in…”
A new era in functional genomics screens
Przybyla, L., & Gilbert, L. A. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-021-00409-w · Cited by 281 · cited 1×
“Functional genomics analysis and systems biology are critical and fundamental for understanding the genetic basis of human health [ 2, 3].”
BioBART: Pretraining and Evaluation of A Biomedical Generative Language Model
Yuan, H., Yuan, Z., Gan, R., Zhang, J., Xie, Y., & Yu, S. (2022) · Workshop on Biomedical Language Processing (BioNLP) · doi:10.18653/v1/2022.bionlp-1.9 · Cited by 244
Alves, R., Gonçalves, A. C., Rutella, S., Almeida, A. M., De Las Rivas, J., Trougakos, I. P., & Sarmento Ribeiro, A. B. (2021) · Cancers · doi:10.3390/cancers13194820 · Cited by 204 · cited 1×
“This discovery has been repeatedly validated through experimental results from BCR-ABL kinase-independent pathways that promote CML cell survival and proliferation, bypassing TKI inhibition [ 84, 85].”
BioBART: Pretraining and Evaluation of A Biomedical Generative Language ModelPreprint
Yuan, H., Yuan, Z., Gan, R., Zhang, J., Xie, Y., & Yu, S. (2022) · Workshop on Biomedical Natural Language Processing · doi:10.48550/arxiv.2204.03905 · Cited by 200
Wagle, M.-C., Kirouac, D., Klijn, C., Liu, B., Mahajan, S., Junttila, M., Moffat, J., Merchant, M., Huw, L., Wongchenko, M., et al. (2018) · npj Precision Oncology · doi:10.1038/s41698-018-0051-4 · Cited by 193 · cited 1×
“…can be enriched by considering different types of activities from various omics sources, such as mutation burden [ 89], transcriptional activity [ 90], proteomics activity [ 91], and metabolic activity [ 92], facilitating deeper insights and more comprehensive interpretations of gene sets and…”
Nayarisseri, A., Khandelwal, R., Tanwar, P., Madhavi, M., Sharma, D., Thakur, G., Speck‐Planche, A., & Singh, S. K. (2021) · Current Drug Targets · doi:10.2174/1389450122999210104205732 · Cited by 167
Nayarisseri, A. (2021) · Current Drug Targets · doi:10.2174/18735592mtezsmdmnz · Cited by 164
GeoMx™ RNA Assay: High Multiplex, Digital, Spatial Analysis of RNA in FFPE Tissue
Zollinger, D. R., Lingle, S. E., Sorg, K., Beechem, J., & Merritt, C. R. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0623-0_21 · Cited by 145 · cited 1×
“…[ 44], KEGG [ 45], BioCarta, WikiPathways [ 46], DMaps [ 47], SPIKE, NCI Nature Curated pathway [ 48], and GeoMx Cancer Transcriptome Atlas [ 49]), ontology annotations (Gene Ontology Annotation [ 50] also known as GOA and Human Phenotype Ontology), tissue-specific expressions (GTEx [ 51],…”
Jabbour, E. J., Cortes, J. E., & Kantarjian, H. M. (2013) · Clinical Lymphoma Myeloma and Leukemia · doi:10.1016/j.clml.2013.03.018 · Cited by 105 · cited 1×
“This discovery has been repeatedly validated through experimental results from BCR-ABL kinase-independent pathways that promote CML cell survival and proliferation, bypassing TKI inhibition [ 84, 85].”
The most common technologies and tools for functional genome analysis
Gasperskaja, E., & Kučinskas, V. (2017) · Acta medica Lituanica · doi:10.6001/actamedica.v24i1.3457 · Cited by 105 · cited 1×
“Functional genomics analysis and systems biology are critical and fundamental for understanding the genetic basis of human health [ 2, 3].”
PANGEA: a new gene set enrichment tool for Drosophila and common research organisms
Hu, Y., Comjean, A., Attrill, H., Antonazzo, G., Thurmond, J., Chen, W., Li, F., Chao, T., Mohr, S. E., Brown, N. H., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad331 · Cited by 96 · cited 1×
“Therefore, the integrative gene sets, networks, and pathways analysis (GNPA) has been introduced and leads the new height of information integration in the recently developed GNPA application [ 40], such as PyGNA [ 41], NDEx IQuery [ 42], PAGER web APP [ 38], and PANGEA [ 43].”
Functional genomics of pain in analgesic drug development and therapy
Lötsch, J., Doehring, A., Mogil, J. S., Arndt, T., Geißlinger, G., & Ultsch, A. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.04.004 · Cited by 70 · cited 1×
“For a deeper understanding of molecular pathways and genetic control mechanisms [ 30], various tools and databases have been developed to perform gene set enrichment analysis by processing a gene list to extract a statistical measure of shared biological features.”
Molecular subtyping of small cell lung cancer
Liang, J., Guan, X., Bao, G., Yao, Y., & Zhong, X. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.05.010 · Cited by 63 · cited 1×
“These include molecular risk stratification [ 6– 8], preclinical drug screening [ 9– 11], prognosis prediction [ 12– 14], new biomarker discovery [ 15– 17], and precision medicine [ 18– 20].”
Metabolic alterations mediated by STAT3 promotes drug persistence in CML
Patel, S. B., Nemkov, T., Stefanoni, D., Benavides, G. A., Bassal, M. A., Crown, B. L., Matkins, V. R., Camacho, V., Kuznetsova, V., Hoang, A. T., et al. (2021) · Leukemia · doi:10.1038/s41375-021-01315-0 · Cited by 56 · cited 1×
“The input consisted of a list of differentially expressed genes in chronic myeloid leukemia (CML) samples resistant and sensitive to tyrosine kinase inhibitors (TKIs) [ 82, 83].”
Self-citationDMAP: a connectivity map database to enable identification of novel drug repositioning candidates
Huang, H., Nguyen, T., Ibrahim, S., Shantharam, S., Yue, Z., & Chen, J. Y. (2015) · BMC Bioinformatics · doi:10.1186/1471-2105-16-s13-s4 · Cited by 55 · cited 1×
“…power, enabling comprehensive analysis from various sources, including pathways (Reactome [ 44], KEGG [ 45], BioCarta, WikiPathways [ 46], DMaps [ 47], SPIKE, NCI Nature Curated pathway [ 48], and GeoMx Cancer Transcriptome Atlas [ 49]), ontology annotations (Gene Ontology Annotation [ 50] also…”
Self-citationA nonredundant role for T cell-derived interleukin 22 in antibacterial defense of colonic crypts
Zindl, C. L., Witte, S. J., Laufer, V. A., Gao, M., Yue, Z., Janowski, K. M., Cai, B., Frey, B. F., Silberger, D. J., Harbour, S. N., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.02.003 · Cited by 49 · cited 1×
“However, the integration of multiple heterogeneous terms remains incomplete, leading to high content-similarity [ 63] or even redundancy [ 64] in the gene set enrichment analysis and network analysis in practice [ 65– 67].”
Self-citationBringing Molecular Prognosis and Prediction to the Clinic
Colozza, M., Cardoso, F., Sotiriou, C. P., Larsimont, D., & Piccart, M. J. (2005) · Clinical Breast Cancer · doi:10.3816/cbc.2005.n.010 · Cited by 48
Dong, H., Li, Z., Bian, S., Song, G., Song, W., Zhang, M., Xie, H., Zheng, S., Yang, X., Li, T., et al. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.03.020 · Cited by 45
Vivar, J. C., Pemu, P., McPherson, R., & Ghosh, S. (2013) · OMICS: A Journal of Integrative Biology · doi:10.1089/omi.2012.0083 · Cited by 44 · cited 2×
“However, the integration of multiple heterogeneous terms remains incomplete, leading to high content-similarity [ 63] or even redundancy [ 64] in the gene set enrichment analysis and network analysis in practice [ 65– 67].”
InfluentialIdentifying a new microRNA signature as a prognostic biomarker in colon cancer
Lv, Y., Duanmu, J., Fu, X., Li, T., & Jiang, Q. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228575 · Cited by 42 · cited 1×
“These include molecular risk stratification [ 6– 8], preclinical drug screening [ 9– 11], prognosis prediction [ 12– 14], new biomarker discovery [ 15– 17], and precision medicine [ 18– 20].”
Berman, E., Jhanwar, S., Hedvat, C., Arcila, M. E., Wahab, O. A., Levine, R., Maloy, M., Ma, W., & Albitar, M. (2016) · Leukemia Research · doi:10.1016/j.leukres.2016.08.006 · Cited by 41
Repositioning drugs by targeting network modules: a Parkinson’s disease case study
Yue, Z., Arora, I., Zhang, E. Y., Laufer, V. A., Bridges, S. L., & Chen, J. Y. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1889-0 · Cited by 41
Self-citationNDEx IQuery: a multi-method network gene set analysis leveraging the Network Data Exchange
Pillich, R. T., Chen, J., Churas, C., Fong, D., Gyori, B. M., Ideker, T., Karis, K., Liu, S. N., Ono, K., Pico, A., et al. (2023) · Bioinformatics · doi:10.1093/bioinformatics/btad118 · Cited by 40 · cited 1×
“Therefore, the integrative gene sets, networks, and pathways analysis (GNPA) has been introduced and leads the new height of information integration in the recently developed GNPA application [ 40], such as PyGNA [ 41], NDEx IQuery [ 42], PAGER web APP [ 38], and PANGEA [ 43].”
Self-citationNGS catalog: A database of next generation sequencing studies in humans
Xia, J., Wang, Q., Jia, P., Wang, B., Pao, W. J., & Zhao, Z. (2012) · Human Mutation · doi:10.1002/humu.22096 · Cited by 40 · cited 1×
“…annotations (Gene Ontology Annotation [ 50] also known as GOA and Human Phenotype Ontology), tissue-specific expressions (GTEx [ 51], NGS Catalog [ 52], and TCGA [ 53], PathologyAtlas [ 54], and FANTOM5 [ 55]), cell-specific expressions (CellAtlas [ 56]), disease phenotypes (GAD, GWAS Catalog […”
Systems Biology for Signaling Networks
Choi, S. (2010) · Systems biology · doi:10.1007/978-1-4419-5797-9 · Cited by 37 · cited 1×
“Early work in signaling network systems biology established the groundwork for these integrative approaches [ 5].”
Discovery of pathway biomarkers from coupled proteomics and systems biology methods
Zhang, F., & Chen, J. Y. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-s2-s12 · Cited by 37 · cited 2×
“Systems biology, when coupled with high-throughput omics technologies like proteomics, allows for the discovery of novel pathway biomarkers, which are essential for understanding complex diseases [ 1].”
Self-citationA novel chemokine‐based signature for prediction of prognosis and therapeutic response in glioma
Fan, W., Wang, D., Li, G., Xu, J., Ren, C., Sun, Z., Wang, Z., Ma, W., Zhao, Z., Bao, Z., et al. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13944 · Cited by 37 · cited 1×
“These include molecular risk stratification [ 6– 8], preclinical drug screening [ 9– 11], prognosis prediction [ 12– 14], new biomarker discovery [ 15– 17], and precision medicine [ 18– 20].”
Prioritizing drug targets in Clostridium botulinum with a computational systems biology approach
Muhammad, S. A., Ahmed, S., Ali, A., Huang, H., Wu, X., Yang, X., Naz, A., & Chen, J. Y. (2014) · Genomics · doi:10.1016/j.ygeno.2014.05.002 · Cited by 36 · cited 1×
“Network-based systems biology approaches have been instrumental in constructing pathway-connected networks, analyzing dose–response relationships, and prioritizing drug targets for repositioning in various diseases, from infectious diseases to cancer [ 27– 29].”
Self-citationBreast cancer subtyping from plasma proteins
Zhang, F., & Chen, J. Y. (2013) · BMC Medical Genomics · doi:10.1186/1755-8794-6-s1-s6 · Cited by 35 · cited 1×
“Network-based systems biology approaches have been instrumental in constructing pathway-connected networks, analyzing dose–response relationships, and prioritizing drug targets for repositioning in various diseases, from infectious diseases to cancer [ 27– 29].”
Self-citationHIP2: An online database of human plasma proteins from healthy individuals
Saha, S., Harrison, S. H., Shen, C., Tang, H., Radivojac, P., Arnold, R. J., Zhang, X., & Chen, J. Y. (2008) · BMC Medical Genomics · doi:10.1186/1755-8794-1-12 · Cited by 34 · cited 1×
“Complementary datasets like HIP2 provide foundational plasma proteomics data for benchmarking and network integration [ 26].”
Self-citationBrugada Syndrome: From Molecular Mechanisms and Genetics to Risk Stratification
Popa, I. P., Șerban, D. N., Maranducă, M. A., Șerban, I. L., Tamba, B.-I., & Tudorancea, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043328 · Cited by 34
Co-embedding of edges and nodes with deep graph convolutional neural networks
Zhou, Y., Huo, H., Hou, Z., Bu, L., Mao, J., Wang, Y., Lv, X., & Bu, F. (2023) · Scientific Reports · doi:10.1038/s41598-023-44224-1 · Cited by 33 · cited 1×
“Co-embedding of PAG–PAG relationships, PAGs, and nodes can be implemented to model multi-dimensional edge features [ 95].”
PAGER: constructing PAGs and new PAG-PAG relationships for network biology
Yue, Z., Kshirsagar, M. M., Nguyen, T., Suphavilai, C., Neylon, M. T., Zhu, L., Ratliff, T., & Chen, J. Y. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv265 · Cited by 30 · cited 2×
“The PAGER database has been instrumental in constructing PAG–PAG relationships and standardizing pathway gene sets for network biology [ 70].”
InfluentialSelf-citationGe, Q., Li, J., Yang, F., Tian, X., Zhang, M., Hao, Z., Liang, C. Y., & Meng, J. (2023) · Annals of Medicine · doi:10.1080/07853890.2023.2279235 · Cited by 28 · cited 1×
“These include molecular risk stratification [ 6– 8], preclinical drug screening [ 9– 11], prognosis prediction [ 12– 14], new biomarker discovery [ 15– 17], and precision medicine [ 18– 20].”
Mohammed, A. E., Alghamdi, S. S., Shami, A., Suliman, R. S., Aabed, K., Alotaibi, M. O., & Rahman, I. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s400195 · Cited by 27 · cited 1×
“These include molecular risk stratification [ 6– 8], preclinical drug screening [ 9– 11], prognosis prediction [ 12– 14], new biomarker discovery [ 15– 17], and precision medicine [ 18– 20].”
Yue, Z., Zheng, Q., Neylon, M. T., Yoo, M., Shin, J., Zhao, Z., Tan, A. C., & Chen, J. Y. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1040 · Cited by 27
Self-citationGaillard, J.-B., Arnould, C., Bravo, S., Donadio, D., Exbrayat, C., Jourdan, E., Reboul, D., Chiesa, J., & Lavabre-Bertrand, T. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0595 · Cited by 23 · cited 1×
“Previous studies showed that aberrant RNA splicing in BCR-ABL variants (BCR-ABL35INS) has been associated with poor response to TKI treatment (Imatinib) [ 86– 88].”
A multi-targeting pre-clinical candidate against drug-resistant tuberculosis
Kaur, P., Potluri, V. K., Ahuja, V. K., Naveenkumar, C. N., Krishnamurthy, R. V., Gangadharaiah, S. T., Shivarudraiah, P., Eswaran, S., Nirmal, C. R., Balasubramanian, M., et al. (2021) · Tuberculosis · doi:10.1016/j.tube.2021.102104 · Cited by 23 · cited 1×
“These include molecular risk stratification [ 6– 8], preclinical drug screening [ 9– 11], prognosis prediction [ 12– 14], new biomarker discovery [ 15– 17], and precision medicine [ 18– 20].”
Soste, M., Charmpi, K., Lampert, F., Gerez, J., van Oostrum, M., Malinovska, L., Boersema, P. J., Prymaczok, N. C., Riek, R., Peter, M., et al. (2019) · Cell Systems · doi:10.1016/j.cels.2019.07.010 · Cited by 22 · cited 1×
“…different types of activities from various omics sources, such as mutation burden [ 89], transcriptional activity [ 90], proteomics activity [ 91], and metabolic activity [ 92], facilitating deeper insights and more comprehensive interpretations of gene sets and putative gene set clusters.”
Woodard, G. A., Kratz, J. R., Haro, G. J., Gubens, M. A., Blakely, C. M., Jones, K. D., Mann, M. J., & Jablons, D. M. (2021) · Clinical Lung Cancer · doi:10.1016/j.cllc.2021.08.008 · Cited by 18 · cited 1×
“These include molecular risk stratification [ 6– 8], preclinical drug screening [ 9– 11], prognosis prediction [ 12– 14], new biomarker discovery [ 15– 17], and precision medicine [ 18– 20].”
Blázquez‐Encinas, R., García‐Vioque, V., Caro-Cuenca, T., Moreno-Montilla, M. T., Mangili, F., Alors‐Pérez, E., Ventura, S., Herrera-Martínez, A. D., Moreno-Casado, P., Calzado, M. A., et al. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04754-8 · Cited by 18
Chowbina, S., Deng, Y., Ai, J., et al. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-s3-s4 · Cited by 16
Inferring metabolic pathway activity levels from RNA-Seq data
Temate‐Tiagueu, Y., Seesi, S. A., Mathew, M., Mandric, I., Rodríguez, Á., Bean, K., Cheng, Q., Glebova, O., Măndoiu, I., Lopanik, N. B., et al. (2016) · BMC Genomics · doi:10.1186/s12864-016-2823-y · Cited by 14
BioRAGent: natural language biomedical querying with retrieval-augmented multiagent systems
Bi, M., Bao, Z., Xie, D., Xie, X., Yang, C., Wang, T., Wang, Y., & Peng, J. (2025) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf539 · Cited by 12 · cited 1×
“5, BART-based variants, SciFive [ 75], Pegasus [ 76], BioGPT [ 77], BioBART [ 78], BioRAgent [ 79], and Flan-T5 [ 80].”
Itonaga, H., Tsushima, H., Imanishi, D., Hata, T., Doi, Y., Mori, S., Sasaki, D., Hasegawa, H., Matsuo, E., Nakashima, J., et al. (2014) · Leukemia Research · doi:10.1016/j.leukres.2013.10.022 · Cited by 12 · cited 1×
“Previous studies showed that aberrant RNA splicing in BCR-ABL variants (BCR-ABL35INS) has been associated with poor response to TKI treatment (Imatinib) [ 86– 88].”
Yue, Z., Slominski, R. M., Bharti, S., & Chen, J. Y. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.820361 · Cited by 11 · cited 2×
“These include adequately covering the extensive content of multi-omics data, rendering complex network-based models, and providing advanced features for in-depth insights in integrative analysis [ 38].”
Self-citationLow c-Kit expression identifies primitive, therapy-resistant CML stem cells
Shah, M., Kumar, H., Qiu, S., Li, H., Harris, M., He, J., Abraham, A., Crossman, D. K., Paterson, A., Welner, R. S., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.157421 · Cited by 11 · cited 1×
“The input consisted of a list of differentially expressed genes in chronic myeloid leukemia (CML) samples resistant and sensitive to tyrosine kinase inhibitors (TKIs) [ 82, 83].”
Self-citationData Mining in Bioinformatics: Selected Papers from BIOKDD
Lonardi, S., & Chen, J. Y. (2010) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2010.28 · Cited by 11
Self-citationLi, X., He, Y., Jiang, Y., Pan, B., Wu, J., Zhao, X., Huang, J., Wang, Q., Cheng, L., & Han, J. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.09.003 · Cited by 11
Laufer, V. A., Chen, J. Y., Langefeld, C. D., & Bridges, S. L. (2017) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2017.04.012 · Cited by 10
Self-citationEnhancing locally adaptive smoothing of graph neural networks via Laplacian node disagreement
Wang, Y., Hu, L., Cao, X., Chang, Y., & Tsang, I. W. (2024) · IEEE Transactions on Knowledge and Data Engineering · doi:10.1109/tkde.2023.3303212 · Cited by 10 · cited 1×
“One solution could be locally adaptive smoothing with signal denoising [ 94].”
Multi-modal quantification of pathway activity with MAYA
Landais, Y., & Vallot, C. (2023) · Nature Communications · doi:10.1038/s41467-023-37410-2 · Cited by 9 · cited 1×
“Additionally, with the prevalence of single-cell data analysis, cell-type-specific and cluster-specific super-PAG can be generated using cell-based multi-omics profiles [ 93].”
In Silico Pharmacology for Evidence-Based and Precision Medicine
Spanakis, M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15031014 · Cited by 9 · cited 1×
“These include molecular risk stratification [ 6– 8], preclinical drug screening [ 9– 11], prognosis prediction [ 12– 14], new biomarker discovery [ 15– 17], and precision medicine [ 18– 20].”
Enhancing Question Prediction with Flan T5 -A Context-Aware Language Model ApproachPreprint
Oza, J., & Yadav, H. S. (2023) · doi:10.22541/au.170258918.81486619/v1 · Cited by 9
In silicoframeworks for systematic pre-clinical screening of potential anti-leukemia therapeutics
Ung, M. H., Varn, F. S., & Cheng, C. (2016) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2016.1243524 · Cited by 7 · cited 1×
“These include molecular risk stratification [ 6– 8], preclinical drug screening [ 9– 11], prognosis prediction [ 12– 14], new biomarker discovery [ 15– 17], and precision medicine [ 18– 20].”
Mining disease-specific molecular association profiles from biomedical literature: a case study
Li, J., Zhu, X., & Chen, J. Y. (2008) · ACM Symposium on Applied Computing · doi:10.1145/1363686.1363984 · Cited by 6
Self-citationNitash, C. G., & Adami, C. (2021) · Physics of Life Reviews · doi:10.1016/j.plrev.2021.06.001 · Cited by 5 · cited 1×
“It enhances our knowledge of pathogenic pathways by examining the interactions between different types of molecules, ultimately creating a comprehensive genotype–phenotype map [ 4].”
Huang, F., Welner, R. S., Chen, J. Y., & Yue, Z. (2024) · Frontiers in Bioinformatics · doi:10.3389/fbinf.2024.1336135 · Cited by 4 · cited 1×
“Integrative systems biology approaches, combined with data mining techniques, have been crucial for uncovering the role of genetic variations in diseases and mining disease-specific molecular association profiles across complex datasets [ 21– 25].”
Self-citationBalestra, C., Maj, C., Müller, E., & Mayr, A. (2023) · PLOS ONE · doi:10.1371/journal.pone.0282699 · Cited by 4 · cited 1×
“However, the integration of multiple heterogeneous terms remains incomplete, leading to high content-similarity [ 63] or even redundancy [ 64] in the gene set enrichment analysis and network analysis in practice [ 65– 67].”
PyGNA: a unified framework for geneset network analysis
Fanfani, V., Cassano, F., & Stracquadanio, G. (2020) · BMC Bioinformatics · doi:10.1186/s12859-020-03801-1 · Cited by 4
GOALS: Gene Ontology Analysis with Layered Shells for Enhanced Functional Insight and VisualizationPreprint
Yue, Z., Welner, R. S., Willey, C. D., Amin, R., & Chen, J. Y. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.22.650095 · Cited by 3
Self-citationAI-driven gene-sets, networks, pathways, and interactions analyses of multi-omics data
Yue, Z., Zhang, Z., Thanh, Q., Nguyen, T. M., Sembay, Z., Chen, H., Welner, R. S., & Chen, J. Y. (2026) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2026.01.023 · Cited by 2 · cited 1×
“Therefore, the integrative gene sets, networks, and pathways analysis (GNPA) has been introduced and leads the new height of information integration in the recently developed GNPA application [ 40], such as PyGNA [ 41], NDEx IQuery [ 42], PAGER web APP [ 38], and PANGEA [ 43].”
Self-citationPyGNA: a unified framework for geneset network analysis
Fanfani, V., Cassano, F., & Stracquadanio, G. (2019) · Figshare · doi:10.5281/zenodo.3574026
Research works printed but not linked: 3
- Zhang, 2013, Breast cancer subtyping from plasma proteins, BMC Med Genomics, 2013, 1
- Lin, 2004, ROUGE: A Package for Automatic Evaluation of Summaries
- OpenAi, 2026, ChatGPT (April Version) [Large Language AI Model]
Metadata
- Authors
- Li, Q., Nichols, C., Welner, R. S., Chen, J. Y., Ku, W.-S., & Yue, Z.
- Affiliations
- Fisk University (US)
- Auburn University (US)
- University of Alabama at Birmingham (US)
- Corresponding author
- Chen, Jake Y
- Ku, Wei-Shinn
- Yue, Zongliang
- Venue
- Briefings in Bioinformatics
- Publisher
- Oxford University Press (OUP)
- Published
- 2026-05
- Volume
- 27
- Issue
- 3
- ISSN
- 1467-5463 (ISSN-L)
- 1477-4054
- PMC
- PMC13200546
- OpenAlex
- W7162300909
- Cited by
- 0
- References
- 81
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Briefings in Bioinformatics (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- University of Alabama at Birmingham Center for Clinical and Translational Science Pilot Award (UM1TR004771)
- Gulf Research Program of the National Academies of Sciences (SCON-10001538)
- University of Alabama at Birmingham (UC267384)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Health Sciences › Medicine › Health Informatics › Biomedical Text Mining and Ontologies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Phylogenetic Studies
- Keywords
- gene expression signatures, graph embedding, domain embedding, large language models, semantic embeddings, feature-level fusion, consensus clustering, Gene Ontology biological process, omics data interpretation, functional genomics
- MeSH terms
- Large Language Models, Humans, Genomics, Gene Regulatory Networks
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.